Letermovir 240mg Tablets Manufacturer & Supplier in India

Taj Pharma stands as a trusted name in the pharmaceutical manufacturing industry, renowned for producing high-quality Letermovir 240mg Tablets. As one of the top manufacturers and exporters of Letermovir Tablets in India, we offer formulations that meet international standards of purity, efficacy, and patient safety. Our manufacturing facility, located in Vapi, Gujarat, adheres to WHO-GMP and ISO certifications, delivering therapeutic excellence for markets in India, Africa, the Middle East, and LATAM.

Letermovir 240mg Tablets – Mechanism and Medical Use

Letermovir is an antiviral medication indicated for the prevention of cytomegalovirus (CMV) infection in CMV-seropositive adult recipients of allogeneic hematopoietic stem cell transplantation (HSCT). It works by inhibiting the CMV DNA terminase complex, which is essential for viral replication, offering targeted action with minimal side effects.

Letermovir is not to be confused with drugs used for leprosy or dermatitis herpetiformis. Its sole clinical indication is CMV prophylaxis post-transplant, ensuring that high-risk individuals are protected from viral reactivation during their immunocompromised state.

Manufacturing Standards and Facility Overview

At Taj Pharma, our advanced manufacturing facility integrates the latest technology to ensure:

  • Batch-to-batch consistency
  • Adherence to BP/USP pharmacopoeial standards
  • Contamination-free production zones
  • Automated packaging lines for enhanced shelf life
  • In-house R&D and quality assurance laboratories

Each batch of Letermovir 240mg Tablets undergoes stringent stability studies, dissolution tests, microbial testing, and impurity profiling to meet global compliance requirements.

Formulation, Dosage & Administration

Letermovir is administered orally, with or without food. The standard dosage is:

  • 240mg once daily
  • Duration: Typically from day 0 to day 100 post-HSCT
  • Monitoring: Liver function tests, CMV viral load, and drug interactions, particularly with cyclosporine or tacrolimus

Our Letermovir Tablets are available in Alu-Alu and blister packs, with customizable bulk packaging for export and institutional use.

Global Reach – Export to Africa, Middle East & Latin America

Taj Pharma has a robust export network supplying Letermovir Tablets to countries across:

  • North and Sub-Saharan Africa
  • Middle Eastern markets including UAE, Saudi Arabia, and Egypt
  • Latin American nations such as Brazil, Colombia, and Mexico

Our logistics and compliance team handles:

  • Product registration support
  • Zone-wise stability data for ICH climates
  • Multilingual labelling and artwork development
  • CTD/ACTD dossiers for regulatory filings

With our long-standing relationships with government healthcare agencies, hospitals, NGOs, and private distributors, we ensure smooth entry into regulated and semi-regulated markets.

Letermovir Tablets for PCD Pharma Franchise and Institutional Supply

Taj Pharma invites strategic partnerships through:

PCD Pharma Franchise

  • Regional monopoly rights
  • Attractive margins
  • Promotional literature and visual aids
  • On-time dispatch and inventory support

Third-Party Manufacturing & Contract Manufacturing

  • Bulk production capacity
  • Private label solutions
  • Regulatory support
  • Low MOQ for startups

Institutional & Government Supply

  • Competitive tender pricing
  • Product certifications
  • Pharmacovigilance support
  • Supply to transplant centres and oncology departments

Why Taj Pharma for Letermovir 240mg Tablets?

  • 25+ years of pharmaceutical experience
  • Fully integrated operations from formulation to export
  • Commitment to patient safety and global compliance
  • Trusted by over 300+ PCD and franchise partners
  • Dedicated CMV prophylaxis portfolio for transplant patients

Side Effects and Safety Profile

Letermovir is generally well-tolerated. However, some common side effects include:

  • Nausea
  • Diarrhea
  • Headache
  • Fatigue
  • Abdominal discomfort
  • Swelling in limbs
  • Cough or respiratory issues

Healthcare professionals are advised to monitor patients for drug interactions and allergic responses during therapy.

PAN India Supply Network

Taj Pharma supplies Letermovir Tablets across India, with efficient distribution to:

  • Mumbai, Maharashtra
  • Delhi NCR
  • Hyderabad
  • Chennai
  • Ahmedabad
  • Bangalore
  • Kolkata
  • Nagpur
  • Jaipur
  • Lucknow

We support hospital procurement, wholesalers, and pharmacy chains through efficient stock management and real-time dispatch tracking.

Letermovir Product Features at a Glance

FeatureDetails
Brand NameTaj Letermovir 240
Generic NameLetermovir
Strength240mg
FormFilm-coated tablet
Packaging10’s / 14’s / 28’s blister or alu-alu
StorageBelow 30°C, away from moisture and sunlight
Shelf Life24-36 months (as per stability studies)
Regulatory SupportCTD/ACTD, FSC, COA, COPP

Therapeutic Value of Letermovir in CMV Prophylaxis

Letermovir is a first-line prophylactic antiviral therapy for post-transplant patients, especially in:

  • Hematopoietic stem cell transplant recipients
  • Oncology patients under immunosuppression
  • High-risk transplant cases with CMV seropositivity

It reduces CMV-related complications, lowers hospitalization duration, and improves graft survival rates.

Documentation and Certifications

Our Letermovir 240mg Tablets come with:

  • Certificate of Analysis (COA)
  • Certificate of Pharmaceutical Product (COPP)
  • Stability Data
  • Free Sale Certificate (FSC)
  • Product Dossier (CTD/ACTD format)

Client Support and After-Sale Services

We offer:

  • 24/7 customer care for international partners
  • Dedicated account managers for PCD partners
  • Real-time shipment tracking
  • Medical information and PV services

Taj Pharma remains the leading manufacturer, supplier, and exporter of Letermovir 240mg Tablets in India, offering unmatched quality, global regulatory support, and a customer-first approach. Our commitment to pharmaceutical innovation and global health solutions continues to drive trust among healthcare providers, patients, and distributors worldwide. Partner with us for high-quality antiviral formulations that deliver proven results in CMV prevention.